Skip to content

Contributions by (RED) to the Global Fund reach $45 million

HIV replication can continue in the intestines even with successful antiretroviral therapy

PrEP could prevent up to three million HIV infections in ten years in Africa

Urinary stones a rare side-effect of atazanavir

Sexual transmission of hepatitis C in HIV-positive gay men reported in Australia

Merck HIV vaccine fails, trials halted

ICAAC: Gains in limb fat and CD4 counts continue three years after switching from d4T to tenofovir

ICAAC: Cross-resistance to 3TC and FTC develops slowly with entecavir monotherapy

ICAAC: Serious but non-AIDS-defining illnesses more frequent at lower CD4 counts and higher viral loads